Clinical data and literature review are important for research, diagnosis, treatment plans, and patient care. These tasks often involve handling large amounts of complex information. Doing these reviews manually takes a lot of time and can have mistakes. This can delay decisions and hurt patient care.
AI helps by automating the process of gathering, analyzing, and understanding clinical data from electronic health records (EHRs) and medical literature. This makes insights faster and more accurate, helping doctors and administrators make better treatment plans and keep patients safer.
A good example is IQVIA’s new AI agents built for the life sciences and healthcare fields. They use NVIDIA’s technology like NIM Agent Blueprints, NeMo Customizer, and NeMo Guardrails. These AI agents improve tasks like identifying targets, reviewing clinical data, evaluating literature, and working with healthcare professionals. IQVIA aims to speed up clinical research, make trial planning faster, and improve healthcare strategies with these AI tools.
In the U.S., where healthcare systems handle a huge amount of patient data every day, advanced AI is very important. It helps medical practices keep up with the latest research and clinical evidence, which benefits patient care.
AI is also changing clinical prediction. Research by Mohamed Khalifa and Mona Albadawy (2024) shows AI works well in eight key areas of healthcare prediction. These areas are diagnosis and early disease detection, predicting disease progression, assessing future risks, predicting how patients will respond to treatments, tracking disease progress, readmission risks, complication risks, and death prediction.
The review showed AI improves both diagnosis and treatment planning. This is especially true in fields like oncology and radiology, which depend on fast-changing research. For medical administrators and IT managers in the U.S., this means AI tools can help doctors make evidence-based decisions quickly.
AI can also predict how a patient will respond to treatment. This helps create personalized medicine that fits each patient’s needs. It leads to better results and avoids side effects or treatments that don’t work.
Medical groups that use AI predictions can improve patient safety by spotting risks before they get worse. This helps meet quality goals and rules commonly followed in U.S. healthcare systems.
Another important use of AI in hospitals and clinics is automating workflows. When AI takes over routine tasks, healthcare workers can spend more time on patient care and complex decisions.
For medical practice administrators and IT managers, AI can improve front-office work. For example, Simbo AI uses AI to automate phone answering. This reduces wait times, improves communication, and lets staff focus on clinical work instead of administrative duties.
AI also helps with literature reviews by quickly searching thousands of research articles and highlighting key findings. This was helpful when IQVIA worked with NVIDIA. Their AI workflows helped researchers and healthcare workers understand large amounts of data quicker. This sped up clinical trials and shortened the time from discovery to market.
AI also tracks the status of clinical assets like drug targets and medical devices. This keeps research teams updated on new developments and rules. Having this current information helps with decision-making and following regulations.
Using AI in clinical data review and patient care in the U.S. requires strict privacy and regulatory compliance. IQVIA uses many privacy technologies and follows strict rules when handling healthcare data. This protects patient privacy according to laws like HIPAA (Health Insurance Portability and Accountability Act).
Medical administrators and IT managers must focus on data security and make sure AI tools follow all federal and state laws. Using AI responsibly is important to keep patient trust and meet standards set by groups such as the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA).
Using AI well in healthcare needs teamwork between doctors, data scientists, IT experts, and management. The research by Khalifa and Albadawy showed that working together is important to safely and effectively use AI.
In the U.S., healthcare groups should build teams with skills in clinical care, administration, technology, and ethics. This teamwork helps solve problems like data quality, system compatibility, algorithm fairness, and patient involvement.
Medical practice administrators and owners should invest in AI training for staff and support a culture that accepts new technology. IT managers have a key role in making sure systems work well together and monitoring AI performance continuously.
IQVIA’s recent work with NVIDIA is a good example for healthcare providers in the U.S. This partnership created AI agents that focus on specific needs in the industry. They support tasks from finding drug targets to engaging healthcare professionals.
Bhavik Patel, President of IQVIA Commercial Solutions, stresses the need for accuracy and efficiency in clinical work. Kimberly Powell, NVIDIA’s Vice President of Healthcare, says AI speeds up clinical trial planning by quickly reviewing large amounts of literature and data, saving valuable time.
IQVIA’s AI tools follow strong privacy, compliance, and patient safety standards. Although used worldwide, they are very relevant for U.S. healthcare systems. Their work shows how AI can improve patient outcomes by making research and clinical processes faster and more accurate.
Accelerated Clinical Trials and Research: AI helps review literature and understand data faster. This speeds up clinical trial development and brings new therapies to patients sooner.
Improved Patient Outcomes: AI improves diagnosis accuracy and predicts risks, helping providers act early and reduce problems.
Resource Optimization: AI automates routine tasks like answering patient calls with tools like Simbo AI. This makes workflows more efficient and frees staff to focus on clinical work.
Regulatory Compliance and Patient Privacy: AI systems built with strong privacy features help practices protect patient information following HIPAA and other rules.
Personalized Medicine: AI supports creating treatment plans that fit each patient. This can improve therapy success and lower side effects.
Data-Driven Decisions: AI tools help clinicians and administrators make decisions based on current research and real-world data.
As AI use grows, it is important to keep checking and teaching about AI. Khalifa and Albadawy emphasize regular monitoring of AI to keep accuracy and reduce bias.
Healthcare groups in the U.S. should:
By using AI responsibly and monitoring it, medical practices can keep patient trust and improve care over time.
Advanced AI technologies are no longer far off; they are here now in U.S. healthcare. Medical practice administrators, owners, and IT managers who use AI for clinical data work, literature management, and workflow automation can help their practices work better, reduce stress, and improve patient care.
Partnerships like IQVIA and NVIDIA show how AI can change healthcare by combining expert knowledge with strong technology. Companies like Simbo AI use AI to improve front-office functions, helping medical offices run smoothly.
For healthcare providers, AI in clinical and administrative work offers clear benefits. These benefits must be balanced with careful attention to privacy, following laws, and ethical use of AI. Careful use helps AI serve patients and healthcare teams well. With smart AI use, faster research, safer care, and better patient outcomes are becoming more possible across the U.S.
IQVIA’s new AI agents, developed with NVIDIA technology, are designed to enhance workflows and accelerate insights specifically for life sciences, helping streamline clinical research, simplify operations, and improve patient outcomes across various stages like target identification, clinical data review, literature review, and healthcare professional engagement.
IQVIA uses NVIDIA’s NIM Agent Blueprints for rapid development, NeMo Customizer for fine-tuning AI models, and NeMo Guardrails to ensure safe deployment. This collaboration enables customized agentic AI workflows that meet the unique needs of the life sciences industry.
Agentic AI provides precision, efficiency, and speed in critical workflows such as planning clinical trials, reviewing literature, and commercial launches, allowing life sciences companies to gain actionable insights faster and improve decision-making.
Use cases include target identification for drug development, clinical data review, literature review, market assessment, and enhanced engagement with healthcare professionals (HCPs), which collectively improve research and commercial processes.
IQVIA integrates deep life sciences and healthcare domain expertise with advanced AI technology to deliver highly relevant, accurate, and compliant AI-powered solutions tailored to the industry’s complex workflows.
IQVIA employs a variety of privacy-enhancing technologies and safeguards, adhering to stringent regulatory requirements to protect individual patient privacy while enabling large-scale data analysis for improved health outcomes.
Healthcare-grade AI® by IQVIA is specifically built for the precision, speed, trust, and regulatory compliance needed in life sciences, facilitating high-quality actionable insights throughout the clinical asset lifecycle.
AI agents accelerate clinical trials by efficiently sifting through vast literature, identifying relevant data, coordinating workflow stages from discovery to commercial application, and reducing time-consuming manual tasks.
The partnership accelerates the development of customized foundation models and agentic AI workflows to enhance clinical development and access to new treatments, pushing the future of life sciences research and commercialization.
IQVIA TechIQ 2025, a two-day conference in London, will feature thought leaders including NVIDIA, exploring strategic approaches to AI implementation in life sciences to navigate the evolving frontier of healthcare AI applications.